| 2017 | RORα2 requires LSD1 to enhance tumor progression in breast cancer
| SCIENTIFIC REPORTS |
| 2014 | RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
| PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
| 2017 | ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition | MUCOSAL IMMUNOLOGY |
| 2018 | ROS-induced cell sheet transfer method and application based on photofunctional materials | Dissertation |
| 2015 | ROS-mediated bidirectional regulation of miRNA results in distinct pathologic heart conditions | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2018 | ROS-Responsive Biomaterial Design for Medical Applications | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY |
| 2010 | Rosacea fulminans with ocular involvement. | BRITISH JOURNAL OF DERMATOLOGY |
| 2012 | Rosai-Dorfman Disease in the breast with increased IgG4 expressing plasma cells: a case report
| KOREAN JOURNAL OF PATHOLOGY |
| 2014 | Rosai-Dorfman Disease in Thoracic Spine : A Rare Case of Compression Fracture
| Korean Journal of Spine |
| 2009 | Rosiglitazone and fenofibrate improve insulin sensitivity of pre-diabetic OLETF rats by reducing malonyl-CoA levels in the liver and skeletal muscle
| LIFE SCIENCES |
| 2013 | Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress
| ENDOCRINE JOURNAL |
| 2008 | Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2008 | Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis | Hormone Research |
| 2009 | Rosiglitazone prevents fatty liver via attenuating SREBP-1 and chREBP in diabetic animal model
| Thesis |
| 2007 | Rosiglitazone protects against alcohol toxicity in non alcoholic fatty liver
| Dissertation |
| 2006 | Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2007 | Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production | JOURNAL OF THE NEUROLOGICAL SCIENCES |
| 2006 | Rosiglitazone relieves acute ethanol-induced hangover in Sprague-Dawley rats
| ALCOHOL AND ALCOHOLISM |
| 2016 | Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
| MEDICINE |
| 2004 | Rosiglitazone 치료 후 adipocytokine 농도와 저밀도 근육량의 변화를 통한 인슐린 저항성의 개선정도
| Journal of Korean Society for the Study of Obesity |
